• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

格拉斯哥预后评分对特发性肺纤维化急性加重患者的预后意义。

Prognostic significance of Glasgow prognostic score in patients with acute exacerbation of idiopathic pulmonary fibrosis.

机构信息

Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

出版信息

Respirology. 2018 Feb;23(2):206-212. doi: 10.1111/resp.13184. Epub 2017 Oct 12.

DOI:10.1111/resp.13184
PMID:29024319
Abstract

BACKGROUND AND OBJECTIVE

The Glasgow prognostic score (GPS) reflects the host systemic inflammatory response and is a validated independent prognostic factor in lung cancer. We investigated GPS as a potential predictive factor of clinical outcomes in idiopathic pulmonary fibrosis (IPF) patients with acute exacerbation (AE).

METHODS

This was a retrospective study performed between January 2006 and March 2016 in Bucheon St. Mary's Hospital, The Catholic University of Korea. Overall, 327 admitted IPF patients were registered in the study. Patients with definite pneumonia at the time of admission, those with left-sided heart failure, pulmonary embolism and an identifiable cause of acute lung injury, and those whose albumin or C-reactive protein levels were not measured were excluded.

RESULTS

A total of 66 patients hospitalized with IPF-AE were finally included. Median survival was 20.7 days and 29 (43.9%) patients died during hospitalization. The median length of overall survival (OS) was 26.0, 20.0 and 15.0 days for GPS-0, GPS-1 and GPS-2, respectively. There were significant differences in OS between GPS-0 and GPS-2 (P = 0.002). In a multivariate analysis performed using a Cox regression model, eosinopenia (P = 0.007), lower partial pressure of oxygen/fraction of inspired oxygen ratio (P = 0.014), and higher GPS (P = 0.006) were independent predictors of mortality.

CONCLUSION

GPS can be helpful in predicting mortality in IPF patients with AE.

摘要

背景与目的

格拉斯哥预后评分(GPS)反映了宿主的全身炎症反应,是肺癌的一个经过验证的独立预后因素。我们研究了 GPS 作为特发性肺纤维化(IPF)急性加重(AE)患者临床结局的潜在预测因素。

方法

这是一项在韩国天主教大学布川圣玛丽医院于 2006 年 1 月至 2016 年 3 月间进行的回顾性研究。总共登记了 327 名住院的 IPF 患者。排除入院时明确肺炎、左侧心力衰竭、肺栓塞和可识别的急性肺损伤原因以及白蛋白或 C 反应蛋白水平未测量的患者。

结果

最终纳入了 66 例住院的 IPF-AE 患者。中位生存时间为 20.7 天,29 例(43.9%)患者在住院期间死亡。GPS-0、GPS-1 和 GPS-2 的中位总生存期(OS)分别为 26.0、20.0 和 15.0 天。GPS-0 和 GPS-2 之间的 OS 有显著差异(P=0.002)。使用 Cox 回归模型进行的多变量分析显示,嗜酸性粒细胞减少(P=0.007)、较低的氧分压/吸入氧分数比值(P=0.014)和较高的 GPS(P=0.006)是死亡率的独立预测因素。

结论

GPS 有助于预测 IPF-AE 患者的死亡率。

相似文献

1
Prognostic significance of Glasgow prognostic score in patients with acute exacerbation of idiopathic pulmonary fibrosis.格拉斯哥预后评分对特发性肺纤维化急性加重患者的预后意义。
Respirology. 2018 Feb;23(2):206-212. doi: 10.1111/resp.13184. Epub 2017 Oct 12.
2
Prognostic value of IFN-γ, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis.γ-干扰素、sCD163、CCL2 和 CXCL10 在特发性肺纤维化急性加重中的预后价值。
Int Immunopharmacol. 2019 May;70:208-215. doi: 10.1016/j.intimp.2019.02.039. Epub 2019 Mar 6.
3
Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.可能预测特发性肺纤维化急性加重期患者死亡率的血清学标志物。
Medicina (Kaunas). 2019 May 13;55(5):132. doi: 10.3390/medicina55050132.
4
Prognostic evaluation by oxygenation with positive end-expiratory pressure in acute exacerbation of idiopathic pulmonary fibrosis: A retrospective cohort study.呼气末正压通气氧合对特发性肺纤维化急性加重期的预后评估:一项回顾性队列研究
Clin Respir J. 2018 Mar;12(3):895-903. doi: 10.1111/crj.12602. Epub 2017 Jan 12.
5
Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.血栓调节蛋白对特发性肺纤维化和非特异性间质性肺炎急性加重期的疗效:一项非随机前瞻性研究。
Drug Des Devel Ther. 2015 Oct 23;9:5755-62. doi: 10.2147/DDDT.S90739. eCollection 2015.
6
Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.特发性间质性肺炎未分类急性加重:与特发性肺纤维化的比较。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620935774. doi: 10.1177/1753466620935774.
7
Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease.血清D-二聚体水平升高与间质性肺疾病急性加重风险增加相关。
Respir Med. 2017 Jul;128:78-84. doi: 10.1016/j.rmed.2017.05.009. Epub 2017 May 19.
8
Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis.血清铁蛋白在特发性肺纤维化急性加重期的预后评估
Clin Respir J. 2018 Aug;12(8):2378-2389. doi: 10.1111/crj.12918.
9
Modified GAP index for prediction of acute exacerbation of idiopathic pulmonary fibrosis in non-small cell lung cancer.改良 GAP 指数预测非小细胞肺癌合并特发性肺纤维化急性加重
Respirology. 2017 Oct;22(7):1379-1385. doi: 10.1111/resp.13075. Epub 2017 May 23.
10
Outcomes of patients admitted to the intensive care unit with idiopathic pulmonary fibrosis.因特发性肺纤维化入住重症监护病房患者的治疗结果。
Crit Care Resusc. 2009 Jun;11(2):102-9.

引用本文的文献

1
Inflammation scores based on C-reactive protein and albumin predict mortality in hospitalized older patients independent of the admission diagnosis.基于C反应蛋白和白蛋白的炎症评分可独立于入院诊断预测老年住院患者的死亡率。
Immun Ageing. 2024 Oct 9;21(1):67. doi: 10.1186/s12979-024-00471-y.
2
Global Leadership Initiative on Malnutrition-Diagnosed Malnutrition in Lung Transplant Candidates.全球营养不良领导倡议-肺移植候选者的营养不良诊断。
Nutrients. 2024 Jan 27;16(3):376. doi: 10.3390/nu16030376.
3
Impact of Dietary Fiber on Inflammation and Insulin Resistance in Older Patients: A Narrative Review.
膳食纤维对老年患者炎症和胰岛素抵抗的影响:叙述性综述。
Nutrients. 2023 May 18;15(10):2365. doi: 10.3390/nu15102365.
4
Combination of computed tomography imaging pattern and severity of respiratory failure as factors associated with prognosis for acute exacerbation of idiopathic chronic fibrosing interstitial pneumonia.计算机断层成像模式与呼吸衰竭严重程度作为特发性慢性纤维化间质性肺炎急性加重预后相关因素的研究。
PLoS One. 2023 Feb 24;18(2):e0279878. doi: 10.1371/journal.pone.0279878. eCollection 2023.
5
Development of a scoring system with multidimensional markers for fibrosing interstitial lung disease.纤维化性间质性肺疾病的多维标志物评分系统的建立。
Sci Rep. 2022 Aug 20;12(1):14217. doi: 10.1038/s41598-022-16382-1.
6
Response to the "Glasgow Prognostic Score as A Marker of Mortality After TAVI".对“格拉斯哥预后评分作为经导管主动脉瓣植入术后死亡率的标志物”的回应
Braz J Cardiovasc Surg. 2022 Dec 1;37(6):963. doi: 10.21470/1678-9741-2021-0577.
7
Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases.特发性肺纤维化急性加重与其他间质性肺疾病之间的差异
Diagnostics (Basel). 2021 Sep 6;11(9):1623. doi: 10.3390/diagnostics11091623.
8
Glasgow prognostic score for prediction of chemotherapy-triggered acute exacerbation interstitial lung disease in patients with small cell lung cancer.格拉斯哥预后评分预测小细胞肺癌患者化疗诱发的急性加重性间质性肺病。
Thorac Cancer. 2021 Jun;12(11):1681-1689. doi: 10.1111/1759-7714.13900. Epub 2021 May 3.
9
Prognostic classification in acute exacerbation of idiopathic pulmonary fibrosis: a multicentre retrospective cohort study.特发性肺纤维化急性加重的预后分类:一项多中心回顾性队列研究。
Sci Rep. 2021 Apr 27;11(1):9120. doi: 10.1038/s41598-021-88718-2.
10
Glasgow Prognostic Score predicts chemotherapy-triggered acute exacerbation-interstitial lung disease in patients with non-small cell lung cancer.格拉斯哥预后评分预测非小细胞肺癌患者化疗诱发的急性加重-间质性肺疾病。
Thorac Cancer. 2021 Mar;12(5):667-675. doi: 10.1111/1759-7714.13792. Epub 2021 Jan 21.